Sanofi's new plan will require institutions to provide pharmacy ... President-elect Donald Trump on Monday pledged big ...

Beyfortus is the first long-acting antibody approved in Canada for the prevention of RSV lower respiratory tract disease in newborns and infants through their first RSV season. Sanofi noted that ...

according to Sanofi. It has also been approved to date in the EU, GB, and Canada. New data from the phase 3b, real-world HARMONIE study has confirmed the efficacy of Beyfortus in clinical trials ...

The latest health news highlights BridgeBio's new heart drug approved by the FDA, novel findings in breast cell research, ...

MAI Capital Management decreased its stake in Sanofi (NASDAQ:SNY – Free Report) by 38.2% during the 3rd quarter, ...

Emcure's growth will be driven by upbeat prospects that the company has across markets in India, Canada and Rest of World, ...

Zacks Research increased their FY2024 EPS estimates for shares of Sanofi in a report issued on Wednesday, November 13th.

On October 21, 2024, Sanofi (NASDAQ: SNY US (ADR), $53.83, Market Cap: $136.6 billion, EN Paris: SAN FP, €100.04, Market Cap: €126.9 billion) announced that it has entered into exclusive ...

The latest health news highlights FDA's approval of BridgeBio's drug for a rare heart condition, cancer features in healthy ...